Table 1_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem... by Shida Pan (12696593)

“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”

Image 3_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem... by Shida Pan (12696593)

“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”

Image 1_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem... by Shida Pan (12696593)

“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”

Comparison of neutrophils, lymphocyte and platelet between the two groups. by Changxu Wang (17826805)

Subjects:

Analysis of correlation of RV-GLS over consecutive quartiles of 25 measurements. by Chantelle M. de Vet (16535257)

Subjects:

Analysis of correlation of LV-GLS over consecutive quartiles of 25 measurements. by Chantelle M. de Vet (16535257)

Subjects:

Standard deviation of the difference between the LV-GLS value of the expert and trainees in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Subjects:

RV-GLS agreement analysis between expert and novice trainees over consecutive quartiles of 25 measurements. by Chantelle M. de Vet (16535257)

Subjects:

S1 File - by Changxu Wang (17826805)

Subjects:

Baseline patient characteristics and surgical and anesthetic datas. by Changxu Wang (17826805)

Subjects:

Standard deviation of the difference between the RV-GLS value of the expert and trainees in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Subjects:

LV-GLS agreement analysis between expert and trainees over consecutive quartiles of 25 measurements. by Chantelle M. de Vet (16535257)

Subjects:

GLS analysis with 2D-STE software. by Chantelle M. de Vet (16535257)

Subjects:

ICC of each trainee RV-GLS value compared with the expert in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Subjects:

ICC of each trainee LV-GLS value compared with the expert in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Subjects:

Mean of the difference between the RV-GLS value of the expert and trainees in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Subjects:

Postoperative pain assessment indexes, nausea and vomiting frequency, and postoperative recovery of patients in two groups. by Changxu Wang (17826805)

Subjects:

The flow chart of the study. by Changxu Wang (17826805)

Subjects:

Mean of the difference between the LV-GLS value of the expert and trainees in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Subjects:

S1 File - by Chantelle M. de Vet (16535257)

Subjects: